SUDEEPPHRM

Sudeep Pharma Share Price

 

 

Start SIP in SUDEEPPHRM

Start SIP

Performance

  • Low
  • ₹631
  • High
  • ₹679
  • 52 Week Low
  • ₹631
  • 52 Week High
  • ₹795
  • Open Price₹651
  • Previous Close₹651
  • Volume1,341,760

Investment Returns

  • Over 1 Month + 13%
  • Over 3 Month + 13%
  • Over 6 Month + 13%
  • Over 1 Year + 13%

Smart Investing Starts Here Start SIP with Sudeep Pharma for Steady Growth!

Invest Now

Sudeep Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 7,569
  • P/B Ratio
  • Average True Range
  • -
  • EPS
  • 12.29
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • -
  • MFI
  • -

Sudeep Pharma Financials

Sudeep Pharma Technicals

EMA & SMA

Current Price
₹670.10
+ 19.1 (2.93%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 1
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

660.13 Pivot Speed
  • R3 736.22
  • R2 707.53
  • R1 688.82
  • S1 641.42
  • S2 612.73
  • S3 594.02

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

N/A

Group Rank

Sudeep Pharma Ltd has an operating revenue of Rs. 1,514.94 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 36% is great, ROE of 28% is exceptional. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 38 which is a POOR score indicating inconsistency in earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Group Rank of 130 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sudeep Pharma F&O

Sudeep Pharma Shareholding Pattern

76.15%
3.44%
0.4%
0.93%
0.8%
7.52%
10.76%

Sudeep Pharma FAQs

Sudeep Pharma share price is ₹670 As on 10 December, 2025 | 01:10

The Market Cap of Sudeep Pharma is ₹7568.7 Cr As on 10 December, 2025 | 01:10

The P/E ratio of Sudeep Pharma is As on 10 December, 2025 | 01:10

The PB ratio of Sudeep Pharma is 11.1 As on 10 December, 2025 | 01:10

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23